- Home
- PRVA
as of 02-24-2026 9:33am EST
Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | ARLINGTON |
| Market Cap: | 2.8B | IPO Year: | 2021 |
| Target Price: | $30.50 | AVG Volume (30 days): | 653.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 14 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.11 | EPS Growth: | -42.11 |
| 52 Week Low/High: | $18.77 - $26.51 | Next Earning Date: | 01-01-0001 |
| Revenue: | $1,736,390,000 | Revenue Growth: | 4.74% |
| Revenue Growth (this year): | 23.19% | Revenue Growth (next year): | 13.51% |
| P/E Ratio: | 197.27 | Index: | N/A |
| Free Cash Flow: | 109.2M | FCF Growth: | +12.29% |
Stock Insider Trading Activity of Privia Health Group Inc. (PRVA)
EVP & Chief Financial Officer
Avg Cost/Share
$25.03
Shares
23,887
Total Value
$597,891.61
Owned After
172,909
SEC Form 4
Director
Avg Cost/Share
$25.01
Shares
13,647
Total Value
$341,311.47
Owned After
68,188
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Mountcastle David | PRVA | EVP & Chief Financial Officer | Dec 12, 2025 | Sell | $25.03 | 23,887 | $597,891.61 | 172,909 | |
| Morris Matthew Shawn | PRVA | Director | Dec 12, 2025 | Sell | $25.01 | 13,647 | $341,311.47 | 68,188 |
Compare PRVA vs Leading Stocks
See how PRVA stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "PRVA Privia Health Group Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.